71 related articles for article (PubMed ID: 1776854)
1. Antagonism of prolactin binding by cyclosporine A on MCF7 breast tumour cell line.
Bernard DJ; Maurizis JC; Sauvezie B; Bignon YJ; Chassagne J; Chollet P; Plagne R
Anticancer Res; 1991; 11(6):2147-51. PubMed ID: 1776854
[TBL] [Abstract][Full Text] [Related]
2. Prolactin receptors in human breast cancer cells in long-term tissue culture.
Shiu RP
Cancer Res; 1979 Nov; 39(11):4381-6. PubMed ID: 227585
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine A inhibition of prolactin-dependent up-regulation of BRCA1 protein expression in human breast cell lines.
Favy DA; Rio PG; Vissac C; Maurizis JC; Bignon YJ; Bernard-Gallon DJ
Anticancer Res; 2000; 20(3A):1703-4. PubMed ID: 10928095
[TBL] [Abstract][Full Text] [Related]
4. Effects of cyclosporine A on Ia antigen expression in N-nitroso-N-methylurea-induced rat mammary tumors.
Bernard DJ; Maurizis JC; Chassagne J; Sauvezie B; Fonck Y; Chollet P; Plagne R
Cancer Res; 1990 Jun; 50(11):3301-5. PubMed ID: 2334922
[TBL] [Abstract][Full Text] [Related]
5. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
Gutzman JH; Miller KK; Schuler LA
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of DNA synthesis by prolactin in human breast tumor explants. Relation to prolactin receptors.
Peyrat JP; Djiane J; Bonneterre J; Vandewalle B; Vennin P; Delobelle A; Depadt G; Lefebvre J
Anticancer Res; 1984; 4(4-5):257-61. PubMed ID: 6091527
[TBL] [Abstract][Full Text] [Related]
7. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine.
Russell DH; Kibler R; Matrisian L; Larson DF; Poulos B; Magun BE
J Immunol; 1985 May; 134(5):3027-31. PubMed ID: 2984281
[TBL] [Abstract][Full Text] [Related]
8. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
Beck MT; Chen NY; Franek KJ; Chen WY
Cancer Res; 2003 Jul; 63(13):3598-604. PubMed ID: 12839947
[TBL] [Abstract][Full Text] [Related]
9. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
10. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L
Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
[TBL] [Abstract][Full Text] [Related]
11. Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific.
Harvey PW
J Appl Toxicol; 2012 Jan; 32(1):1-9. PubMed ID: 22095846
[TBL] [Abstract][Full Text] [Related]
12. Prolactin and human tumourogenesis.
Fernandez I; Touraine P; Goffin V
J Neuroendocrinol; 2010 Jul; 22(7):771-7. PubMed ID: 20456598
[TBL] [Abstract][Full Text] [Related]
13. Prolactin receptors in human breast tumors.
Turcot-Lemay L; Kelly PA
J Natl Cancer Inst; 1982 Mar; 68(3):381-3. PubMed ID: 6278192
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
[TBL] [Abstract][Full Text] [Related]
15. The nuclear prolactin receptor: a 62-kDa chromatin-associated protein in rat Nb2 lymphoma cells.
Rao YP; Buckley DJ; Buckley AR
Arch Biochem Biophys; 1995 Oct; 322(2):506-15. PubMed ID: 7574727
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of the prolactin receptor expression in human breast cancer.
Galsgaard ED; Rasmussen BB; Folkesson CG; Rasmussen LM; Berchtold MW; Christensen L; Panina S
J Endocrinol; 2009 Apr; 201(1):115-28. PubMed ID: 19153125
[TBL] [Abstract][Full Text] [Related]
17. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of prolactin in human mammary tumors.
Thorpe SM; Daehnfeldt JL
Eur J Cancer (1965); 1980; Suppl 1():45-51. PubMed ID: 6274640
[No Abstract] [Full Text] [Related]
19. Regulation of prolactin receptor expression by the tumour promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human breast cancer cells.
Ormandy CJ; Lee CS; Kelly PA; Sutherland RL
J Cell Biochem; 1993 May; 52(1):47-56. PubMed ID: 8320275
[TBL] [Abstract][Full Text] [Related]
20. Prolactin binding and localization in rat mammary tumor mast cells.
Hafez MM; Costlow ME
Cancer Res; 1988 Jul; 48(13):3765-71. PubMed ID: 3288335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
